Kentucky LEADS Collaborative: Lung Cancer Survivorship Care Program
Public ClinicalTrials.gov record NCT02989974. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Kentucky LEADS Lung Cancer Survivorship Care Program - Survivors and Caregivers
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The objective of the Kentucky LEADS Lung Cancer Survivorship Care Program is to develop, administer and evaluate the impact of a comprehensive psychosocial survivorship care program for individuals diagnosed with lung cancer and their caregivers to improve lung cancer survivorship and delivery of high-quality lung cancer care. The investigators hypothesize that the Kentucky LEADS Lung Cancer Survivorship Care Program will demonstrate improved quality of life, better symptom control, increased tobacco treatment, and reduced distress among lung cancer survivors and their caregivers.
Study identification
- NCT ID
- NCT02989974
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 214 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 9, 2017
- Primary completion
- Apr 23, 2019
- Completion
- Apr 23, 2019
- Last update posted
- Oct 28, 2020
2017 – 2019
United States locations
- U.S. sites
- 9
- U.S. states
- 1
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Kings Daughters Medical Center - Ashland | Ashland | Kentucky | 41101 | — |
| Commonwealth Cancer Center - Danville | Danville | Kentucky | 40422 | — |
| Hardin Memorial Health - Elizabethtown | Elizabethtown | Kentucky | 42701 | — |
| Hazard ARH Regional Medical Center | Hazard | Kentucky | 41701 | — |
| Markey Cancer Center | Lexington | Kentucky | 40536 | — |
| UofL/Brown Cancer Center - Louisville | Louisville | Kentucky | 40202 | — |
| Baptist Health - Madisonville | Madisonville | Kentucky | 42431 | — |
| St. Claire Regional Medical Center - Morehead | Morehead | Kentucky | 40351 | — |
| Owensboro Health | Owensboro | Kentucky | 42303 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02989974, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 28, 2020 · Synced Sep 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02989974 live on ClinicalTrials.gov.